ArticleGastro hep advances2026
A Shared Medical Appointment Program to Improve Self-management of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease, with a rising global prevalence exceeding 30%. Effective lifestyle intervention programs are critically needed to enhance the self-management of individuals with MASLD. We implemented Behavioral Resources and Intervention through Digital Group Education (BRIDGE), a 6-session, group telehealth psychoeducational program in shared medical appointments in an academic outpatient hepatology clinic. The aim of this study is to evaluate the program's impact on participants' knowledge, confidence, and self-efficacy in managing MASLD. Methods: In a single-arm quasi-experimental study from January 2022 to May 2024, BRIDGE participants completed preintervention and postintervention surveys. We analyzed demographic and clinical data from medical records and survey responses assessing for change in knowledge and confidence in managing MASLD, self-efficacy in managing psychosocial health and accessing health information, and self-reported physical activity. Results: Seventy MASLD patients participated, including 25 transplant recipients. The median age of participants was 57, with 49% female, 44% non-Hispanic White, 29% Hispanic, 23% with cirrhosis, 41% with diabetes, and a median body mass index of 32.5. Postintervention surveys demonstrated significant improvements in knowledge, confidence in making health behavioral changes, and increased self-efficacy in managing emotions and accessing health information. Conclusion: The BRIDGE telehealth shared medical appointment program enhances self-management in patients with MASLD by improving knowledge and confidence in making meaningful changes in health-related behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.